Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Ordinary Shares | Options Exercise | $636K | +11.5K | +14.03% | $55.32 | 93.4K | Jun 28, 2021 | Direct | F1, F2, F3 |
transaction | MDT | Ordinary Shares | Sale | -$1.44M | -11.5K | -12.31% | $125.29 | 81.9K | Jun 28, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDT | Stock Option (Right to Buy) | Options Exercise | $0 | -11.5K | -88.59% | $0.00 | 1.48K | Jun 28, 2021 | Ordinary Shares | 11.5K | $55.32 | Direct | F1, F4, F5, F6 |
Id | Content |
---|---|
F1 | The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
F2 | This amount has been adjusted to correct a mathematical error in exempt transactions such as dividend reinvestment. |
F3 | This balance increased by 266 shares due to exempt transactions such as dividend reinvestment. |
F4 | This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. |
F5 | This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option. |
F6 | This amount has been adjusted to correct a mathematical error that occurred in Column 9 in the previously filed Form 4 on April 7, 2021. |